Moderna today began clinical trials for a flu shot that uses the same mRNA technology deployed in COVID-1984 jabs •US-based company will administer one dose of the jabs to 560 people •Participants will then be monitored for side effects and immune reactions •mRNA jabs are the second and third against flu to enter clinical trials ARTICLE 355 views02:41